Ribonucleic Acid (RNA) Markers Market, by Type (Prestained Markers, Unstained Markers and Specialty Markers), by Application (Nucleic Acid Applications and Proteomics Applications), by End User (Research Centers, Pharmaceutical and Biotechnology Companies and Others (Academic Institutes, Forensic Laboratory and Others)) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2023

Code : CMI5584

Pages :195

Formats :

Excel and PDF

Industry : Biotechnology

Ribonucleic Acid (RNA) Markers MarketSize and Trends

Global ribonucleic acid (RNA) markers market is estimated to be valued at US$ 226.6 million in 2023 and is expected to exhibit a CAGR of 8.76% during the forecast period (2023-2030). Increasing investment for research and development activities by the government is expected to assist in the growth of the market over the forecast period. For instance, in the year 2020, Sanofi, a pharmaceutical company and GSK, a pharmaceutical and Biotechnology Company, entered into a collaboration agreement with the U.S. government, in order to increase the development and manufacturing of a COVID-19 recombinant protein-based vaccine. Under this agreement, the U.S. government provided US$ 2.1 billion, which was used for the development of vaccine, clinical trials, scale up and distribution of approximately 100 million doses of vaccines.

The ribonucleic acid (RNA) markers market's growth is expected to increase over the forecast period. This is due to the increasing demand of RNA vaccines, especially during the COVID-19 pandemic as many manufacturers started conducting more research and development activities for the production of COVID-19 mRNA vaccines. Moreover, the demand of RNA markers will also increase in future for the development of new medicines and vaccines.

Figure 1.Global Ribonucleic Acid (RNA) Markers Market Share (%), by Type, 2023

Global Ribonucleic Acid (RNA) Markers Market- Driver

Facility expansion by the market players to drive the growth of the Ribonucleic Acid (RNA) Markers Market

Market players are indulged in facility expansion, which is expected to increase the production of nucleic acid products including RNA markers, which is expected to drive the growth of the Ribonucleic Acid (RNA) markers market over the forecast period. For instance, in November 2022, Celerion, a clinical research organization (CRO), expanded its molecular and cellular capabilities to Good Laboratory Practice/Good Clinical Practice (GLP/GCP) standards, in order to support the development of new modality therapies, such as cell and gene therapies. The expanded service offering is available in both of the company’s locations, i.e., Lincoln and Zürich bioanalytical laboratories and this includes ELISpot analysis, flow cytometry, and qPCR

Figure 2. Global Ribonucleic Acid (RNA) Markers Market Share (%), by Region, 2022